The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
2019; Nature Portfolio; Volume: 575; Issue: 7781 Linguagem: Inglês
10.1038/s41586-019-1694-1
ISSN1476-4687
AutoresJude Canon, Karen Rex, Anne Y. Saiki, Christopher Mohr, Keegan S. Cooke, Dhanashri Bagal, Kevin Gaida, Tyler Holt, Charles G. Knutson, Neelima Koppada, Brian A. Lanman, Jonathan Werner, Aaron S. Rapaport, Tisha San Miguel, Roberto Ortiz, Tao Osgood, Ji-Rong Sun, Xiaochun Zhu, John D. McCarter, Laurie P. Volak, Brett E. Houk, Marwan Fakih, Bert H. O’Neil, Timothy Price, Gerald S. Falchook, Jayesh Desai, James Kuo, Ramaswamy Govindan, David S. Hong, Wenjun Ouyang, Haby Henary, Tara Arvedson, Victor J. Cee, J. Russell Lipford,
Tópico(s)Cell Adhesion Molecules Research
Referência(s)